ArticleTransplantation and cellular therapy2025

Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.

Cindy Lynn Hickey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.